Polyethylene glycol (PEG) is effective as a fusing agent for the rescue of virus from Rous sarcoma virus-transformed mammalian cells. The procedure for PEGmediated rescue of virus from virogenic cell lines is described, and the technique is compared with that of Sendai virus-mediated rescue. Virus may be rescued quantitatively from virogenic cell lines by plating mitomycin C-killed transformed mammalian cells with chicken embryo cells, treating the monolayers with 50% PEG and overlaying the monolayers with focus agar. The number of foci that appeared reflected the number of heterokaryons in the fusion mixtures that released infectious virus. PEG gave reproducible results in virus rescue experiments with an efficiency equal to the best Sendai virus preparations. In addition to the description of the technique for PEG-mediated virus rescue from virogenic cell lines, a method for virus rescue from nonvirogenic lines is presented. Preinfection of the chicken embryo cells with helper avian leukosis virus (Rous-associated virus) prior to fusion with mammalian cells transformed by defective viruses complements the virus defect. We examined four nonvirogenic cell lines, and all released infectious virus in the complementation rescue assay.
The induction of tumors in animals and the morphological transformation of cells in tissue culture by Rous sarcoma virus (RSV) has been described for a variety of mammalian species (21, 22) . Although the majority of RSV-transformed mammalian cells do not release infectious virus (11, 21) , several lines of evidence indicate that the virus persists in these cells. Some of the markers for RSV expression that have been examined include: (1) avian virus group-specific antigens (30) ; (ii) RSV tumorspecific surface antigens (15) ; (iii) RSV-specific DNA (25, 26) ; (iv) RSV-specific RNA (9) ; and (v) reverse transcriptase-containing particles (6) . However, the most convincing evidence for the persistence of the RSV genome is the ability to rescue infectious virus from certain RSV-transformed mammalian cell lines (5, 16, 21, 23, 24) .
Even though it has been possible to demonstrate the presence of RSV-specific markers in transformed mammalian cells, it has not been possible to rescue virus from all of these lines. Thus, some lines have been referred to as virogenic and others as nonvirogenic. Virogenic cells generate tumors upon injection into chickens, and virus that has a subgroup similar to the original virus used to transform the cells is recovered (21) . Virus rescue may also be demonstrated in vitro by fusion of the transformed mammalian cells with chicken embryo cells (5, 16, 21, 23, 29) . Nonvirogenic lines fail to release virus in either of these assays (21, 24) .
The failure to rescue virus from some RSVtransformed mammalian cell lines, in spite of their expression of some viral-specific markers, has not been explained. One attractive hypothesis is that the RSV genome in these nonvirogenic lines contains a deletion of viral genes. Thus, any virus rescued would be defective. It should be possible to complement this defect by using a nontransforming avian leukosis virus to supply the missing replication gene(s). This report describes an efficient complementation rescue assay, and we demonstrate that all four nonvirogenic RSV-transformed mammalian cell lines that we have examined can be complemented by avian leukosis virus.
The study of virus rescue from avian sarcoma virus (ASV)-transformed mammalian cells has been limited by the difficulties encountered in hybridizing cells. Sendai virus is effective in inducing cell fusion, but it is difficult to prepare and lacks reproducibility from batch to batch.
In addition, Sendai virus-mediated rescue assays are difficult and tedious (2) . These problems make it virtually impossible to perform rescue assays routinely and on a large scale.
Recently, a series of papers on the effectiveness of polyethylene glycol (PEG) in inducing somatic cell hybridization have been published (7, 8, 20) . The possibility of using PEG (2) .
(ii) PEG-mediated virus rescue. The described procedure was adapted to virus rescue (see below) by a modification of the PEG-monolayer fusion technique of Davidson and Gerald (7). Fifty percent PEG was prepared as described by Pontecorvo (20) . Briefly, 10 g of PEG 6000 (molecular weight 6,000 to 7,500; J. T. Baker Chemical Co.) was autoclaved, and 10 ml of E at 37°C (without serum) was added. This solution was mixed well and cooled to room temperature. If crystals appeared, the solution was incubated at 56°C until a crystal-free solution was obtained.
Transformed mammalian cells were treated with 10 ,ug of mitomycin C per ml for 2 h three days after subculture. 106 freshly transferred CEC in 100-mm tissue culture dishes. Twelve hours after virus exposure, the cultures were killed by incubation with 10 ,ug of mitomycin C per ml for 2 h. The killed infected cells were trypsinized and absorbed at various densities in 0.1 ml of EC5 onto fresh monolayers of CEC for 15 min before they were overlaid with standard focus agar. The infected cells were plated early after infection, before they had begun to release free virus, to ensure that foci arising were a direct measurement of the virus-producing cells in the culture.
(ii) Virus-producing heterokaryons. B4 cells (5 x 105 cells) were plated with 2.5 x 106 RAV-infected CEC in 60-mm tissue culture dishes. Four hours after plating, the cells were treated with 5 ml of PEG for 1 min, rinsed three times with TD, and then fed with EC5 containing 10 ,ug of mitomycin C per ml. After incubation with mitomycin C for 2 h, the cultures were fed EC5 (without mitomycin C). After 12 h, the cultures were trypsinized, and the cells were replated on fresh monolayers of indicator chicken cells in 2.0 ml of EC,. Three hours after seeding, the cultures were overlaid with standard focus agar. Foci resulting on uninfected C/E cells are a direct measurement of the number of infectious virus-producing heterokaryons in the fusion mixture.
RESULTS PEG-mediated virus rescue from B77 virustransformed NRK cells. To evaluate the usefulness of PEG for virus rescue studies, it was desirable to begin with an ASV-transformed mammalian cell line that was known to be virogenic. Virus has been successfully rescued from the B77 virus-transformed cell line NRK/ B77 T1 by Sendai virus fusion with CEC (3). Monolayers of CEC and mitomycin C-killed NRK/B77 T1 cells were treated with 50% PEG for 1 min, rinsed, fed, and overlaid with focus agar as described above. Eighteen separate PEG-mediated virus-rescue experiments, performed in duplicate over a period of 4 The procedure routinely used for PEG-mediated virus rescue combines cell fusion and the focus assay for ASV. For a focus to appear, virus must be released from the mitomycin Ckilled transformed mammalian cell-CEC hybrid and must infect the neighboring CEC (28, 29) . The background of focus formation by mitomycin C-killed NRK/B77 T1 cells in the absence of fusing agent is most likely due to spontaneous heterokaryon formation during cocultivation. Spontaneous fusion and virus rescue have been observed previously (28) . The frequency of virus rescue in the absence of fusing agents is usually 100-(23) to 300-fold (29) lower than that with added Sendai virus. There is a 200-fold increase in rescue frequency with PEG treatment. Presuming that the frequency of spontaneous fusion is 10-4 for ASV-transformed mammalian cells cocultivated with a fivefold excess of chicken cells (28) , the expected rescue frequency for NRK/B77 T1 cells would be 0.1 to 0.2 FFU/103 cells. This agrees well with the observed frequency of 0.09 FFU/103 cells in the absence of fusing agents. Furthermore, spontaneous rescue in vitro in the absence of fusing agents was observed for the two other virogenic lines, LR3/3 and LR5/1, described in this communication.
The effect of chicken cell density on the virus rescue frequency was examined by plating 104 mitomycin C-killed NRK/B77 T1 cells with various densities of CEC ranging from 1 x 105 to 8 x 105 CEC per 35-mm dish. There were no significant differences observed with the various CEC cell densities. For standardization, the rescue assay was routinely performed with 4 x 105 to 5 x 105 CEC.
To maximize the rescue assay, the optimum times between cell seeding and PEG treatment before agar overlay were determined (data not shown). The frequency of virus rescue decreased by 50% if PEG treatment was carried out 6 h as compared with 24 h after cell plating. Agar overlay at 2 h, but not 6 or 24 h, after PEG J. VIROL. A number of variations in the standard procedure were also attempted. Varying the number of TD washes or increasing the volume of PEG did not affect significantly the rescue frequency. Only increasing (62%) or decreasing (41%) the PEG concentration or neutralizing the PEG (which is normally slightly acidic when mixed with Eagle medium) resulted in a substantial decrease in the rescue frequency (Table 2 ). In addition, PEG 1000 or 1540 resulted in rescue frequencies comparable to those observed for PEG 6000, but PEG 600 was only about 10% as effective in the fusion assay ( Table 2) .
Comparison of clones with a range of virus rescue frequencies. SR3 is a line of SchmidtRuppin virus-transformed BHK 21/13 cells which exhibits a high frequency of reversion to the normal nontransformed morphology (18) . A series of subclones displaying various degrees of reversion were isolated and compared with the parent line in quantitative virus rescue experiments (2) . A direct correlation between morphological reversion and rescue frequency was observed; revertant subclones exhibited low rescue frequencies, and transformed variants exhibited high rescue frequencies. In addition, morphology and virus rescue frequencies reflected the levels of virus-specific mRNA expression in these cells (9) .
Virus rescue by PEG-mediated fusion was Rescue by fusion of mitomycin C-killed B4 cells with monolayers of RAV-infected chicken cells was examined for leukosis viruses of subgroups A, B, and C. RAV-infected cultures were prepared by infecting secondary cultures of CEC with the appropriate virus and passaging the cells twice before use to ensure complete infection. The assay was performed by plating mitomycin C-killed B4 cells with RAV-infected chicken cells, treating the monolayers with PEG, and overlaying with focus agar exactly as described above (Table 4) .
As predicted, attempts to rescue virus from B4 cells by fusion with chf-gs-CEC failed. There are two possible explanations for these results: (i) the RAV-infected CEC were not fully infected (in the case of RAV-1 and the C subgroup RAVs) and hence, the interference was incomplete; and (ii) since the heterokaryons are infectious centers which continuously release virus, there may be differences between the various subgroups in resistance to infectious center challenge. These two possibilities were examined by comparing virus challenge and infectious center challenge of cells infected with the various leukosis viruses.
Interference data for RAV-infected cultures challenged with virus are presented in Table 5 . Cells infected with RAV-7, RAV-49, and NTB77 restrict focus formation by challenging PRC virus by only 10-to 12-fold. Therefore, the appearance of foci in the subgroup C rescue of B4 virus may be the result of incomplete interference. This weak interference may also be the result of heterogeneity in interference patterns normally observed among the C subgroup viruses (11) . The Sarcoma virus infected cells (PRA or PRB) were plated as infectious centers (see above) on uninfected C/E chicken cells, cells infected with leukosis virus of the same subgroup, and genetically resistant cells (Table 5 ). PRA cells plated at infectious centers resulted in foci on monolayers of RAV-1-infected cells at an efficiency of approximately two foci per 103 infectious centers. The virus released from the PRA cells is subgroup A, as determined by its inability to infect C/A cells. PRB cells, however, did not produce foci when plated as infectious centers on monolayers of RAV-6-infected cells. In addition, no foci were evident when PRB cells were plated as infectious centers on subgroup B genetically resistant quail cells. It appears that although the RAV-1-and RAV-6-infected cultures interfere equally as efficiently with a direct virus challenge, subgroup A sarcoma virus-infected cells are able to overcome superinfection resistance and infect subgroup A leukosis virus-infected cells.
To test directly if the differences in efficiency of interference with virus-producing cells provides a suitable explanation for the RAV-1 and (Table 7) . Virus could not be rescued from KC cells, which are a human glioma cell line transformed in vitro by RSV, by fusion with C/E CEC. This was an unexpected result considering the report that group-specific antigen is expressed in these cells and that virus may be rescued upon injection of KC cells into chickens (17) . upon fusion with C/E CEC. Virus was rescued from the other two lines LR3/1 and LR/3 only in complementation rescue assays. PEG-mediated fusion has been used to detect virus in both virogenic and nonvirogenic cell lines. Of four SRD-transformed rat embryo cell lines isolated, two proved to be nonvirogenic upon fusion with C/E cells. Thus, the isolation of nonvirogenic lines from which transforming virus may be rescued by the complementationrescue procedure may be a common event. The properties of the virus rescued from nonvirogenic cells is currently under investigation in an attempt to determine which function(s) is defective. DISCUSSION Although Sendai virus is an effective fusing agent in the rescue of RSV from transformed mammalian cells, it suffers from certain technical drawbacks. The fusing capacity may vary from batch to batch, it is somewhat difficult to prepare, and it has a limited storage life. These problems assume major importance if one is planning to do rescue experiments only occasionaly or on a large scale. PEG-mediated cell fusion induces reproducible heterokaryon and somatic cell hybrid formation (7, 8 (14, 29) , previous attempts to rescue virus from nonvirogenic cell lines by complementation have failed (24) . This reflects the increased efficiency of our complementationrescue technique. The nonvirogenic cell lines examined by Svoboda et al. (24) may be transformed by viruses that are too defective to rescue, as they suggest. However, it is likely that their assay, which involves titrating the transforming virus in the supernatant from nonvirogenic cells fused with leukosis virus-infected chicken cells, lacks the sensitivity to detect transforming virus among the vast excess of RAV that is present. It will be interesting to screen other nonvirogenic lines in our complementation-rescue assay to determine if actual rescue-negative RSV-transformed mammalian cell lines exist.
The fusion-rescue assay requires that the virus produced from the heterokaryons of transformed mammalian cells and CEC reinfects the neighboring CEC to produce a focus. B4 cells fused with normal chicken cells produce no infectious virus but would produce foci if a round of infection was unnecessary. The production of foci by complementation with RAV-1 (and the subgroup C leukosis viruses), however, presents a dilemma. The virus produced from the heterokaryons should have an RAV-1 envelope and host range. Since all of the neighboring CEC are infected with RAV-1 and resistant to superinfection, the complementation rescue assays should not work. Several experiments have been done in an attempt to resolve this paradox.
CEC producing PRA virus and killed with mitomycin C are incapable of producing foci on C/A genetically resistant cells, but do give rise to a reduced number of foci on RAV-1-infected cells (Table 5 ). B4 cells, fused with RAV-1-infected cells and plated as infectious centers on RAV-1-infected cells, also give rise to foci ( Table 6 ). The efficiency of infection of cells resistant to subgroup A viruses (due to interference) by contact with either PRA virus-producing chicken cells or heterokaryons-producing B4 (RAV-1) pseudotypes is approximately 2 x 1O-3 of the actual virus-producing cells. The efficiency of infection of subgroup B leukosis virus-infected cells by subgroup B sarcoma virus-producing cells is less than 10-5. With 105 PRB or infectious RAV-6 x B4 heterokaryons plated as infectious centers on monolayers of RAV-6-infected cells, no foci resulted. Considering these results, it is evident that the successful rescue of virus from B4 cells by fusion with RAV-1-infected CEC in the monolayer rescue assay is due to the ability of cells producing subgroup A viruses to overcome subgroup-specific interference. The RAV-6 complementation in the monolayer rescue was 100-fold less efficient and may be explained on the basis of the apparent inability of subgroup B virus-producing cells to efficiently infect RAV-6-infected cells.
The complementation rescue procedure has been applied to several other RSV-transformed mammalian cell lines. Although this method is much less sensitive than replating fusion mixtures as infectious centers on uninfected cell monolayers, it does provide a means for rapid screening of cell lines for the presence of defective viruses. In addition to B4 cells, a line of RSV-transformed human astrocytes (KC cells [171) and two lines of SRD-transformed Lewis rat embryo cells (LR3/1 and LR3/2), all of which fail to release infectious virus in rescue assays with uninfected CEC, have been tested. All four of these rescue-negative RSV-transformed cell lines register as rescue positive upon fusion with RAV-1-infected CEC.
The procedure for rescue of virus from nonvirogenic cell lines has been referred to as a "complementation rescue assay." We have not yet determined if our results are due to complementation, recombination, or both. In the case of B4 cells, the virus rescue is most likely due to complementation and not recombination. It is known that Bryan virus does not recombine with helper virus to form nondefective transforming progeny virus. It is unlikely that recombination is necessary for the release of infectious virus from the heterokaryons in the rescue of virus from other nonvirogenic lines. Both the RAV-infected CEC and the transformed mammalian cells may be killed with mitomycin C before fusion without affecting the rescue frequency (not shown). It has been established that mitomycin C-killed chicken cells are not capable of being infected by virus but that infected cells continue to release virus after killing. Unless recombination is occurring at the RNA level, recombination is not likely to be a prerequisite for rescue of defective virus from transformed cells. This does not, however, imply that recombination with helper virus does not occur in later rounds of infection. We are currently examining the virus rescued from the various cell lines for the presence of recombinants. 
